The Vanguard Group 13D and 13G filings for Inspire Medical Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-10-04 2:09 pm Purchase | 2024-09-30 | 13G | Inspire Medical Systems, Inc. INSP | The Vanguard Group | 3,232,138 10.830% | 300,669 (+10.26%) | Filing |
2024-02-13 5:06 pm Sale | 2023-12-29 | 13G | Inspire Medical Systems, Inc. INSP | The Vanguard Group | 2,931,469 9.930% | -46,922 (-1.58%) | Filing |
2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Inspire Medical Systems, Inc. INSP | The Vanguard Group | 2,978,391 10.310% | 78,489 (+2.71%) | Filing |
2022-11-10 11:21 am Purchase | 2022-10-31 | 13G | Inspire Medical Systems, Inc. INSP | The Vanguard Group | 2,899,902 10.040% | 340,163 (+13.29%) | Filing |
2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Inspire Medical Systems, Inc. INSP | The Vanguard Group | 2,559,739 9.360% | 157,768 (+6.57%) | Filing |
2021-02-10 11:03 am Purchase | 2020-12-31 | 13G | Inspire Medical Systems, Inc. INSP | The Vanguard Group | 2,401,971 8.920% | 2,401,971 (New Position) | Filing |